Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

Elvia Cowan Sells 3,000 Vaxcyte Shares After Option Exercise

Elvia Cowan, SVP, Finance and Chief Accounting Officer of Vaxcyte, Inc. (NASDAQ:PCVX), filed a Form 4 on November 4, 2026, disclosing transactions dated November 2, 2026, involving the exercise of stock options and the subsequent sale of common stock under a Rule 10b5-1 trading …

Anjali Anand | 04 November 2026

Universal Corporation Q2 FY2027: Net Income Falls to $12.6M

Universal Corporation filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 4, 2026, reporting second-quarter and six-month financial results for its fiscal year.

Shwetambri Chauhan | 04 November 2026

Coca-Cola Consolidated Q3 2026: Net Sales Hit $1.99B

Coca-Cola Consolidated, Inc. filed its Form 10-Q for the quarterly period ended October 2, 2026 with the U.S. Securities and Exchange Commission on November 4, 2026, reporting third-quarter and first-nine-months financial results.

Manish Choudhary | 04 November 2026

Advantage Solutions Q3 2026: Net Loss Widens to $159.6M

Advantage Solutions Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 4, 2026, reporting a net loss of $25.1 million for the third quarter and a year-to-date net loss of $159.6 million.

Anjali Anand | 04 November 2026

Universal Corp Appoints Gregory R. Friedman to Board

Universal Corporation filed a Form 8-K on November 4, 2026, disclosing the appointment of Gregory R. Friedman as a new director and an expansion of the Board of Directors from nine to ten members, both effective immediately.

Aakashdeep | 04 November 2026

Bio-Rad Q3 2026 Earnings Results Announced Nov. 4

Bio-Rad Laboratories, Inc. filed a Form 8-K on November 4, 2026, announcing its financial results for the quarter ended September 30, 2026, and furnishing a press release and supplemental earnings presentation as exhibits.

Vinay Lochav | 04 November 2026

Pennant Group Q3 2026: Revenue Hits $302.3M

The Pennant Group, Inc. filed its quarterly report on Form 10-Q with the SEC on November 4, 2026, covering the three and nine months ended September 30, 2026.

Manish Choudhary | 04 November 2026

Bio-Rad Q3 2026: Net Sales $656.4M, Intangibles Impairment Hit

Bio-Rad Laboratories, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the Securities and Exchange Commission on November 4, 2026, reporting third-quarter net sales of $656.4 million and an operating loss driven in part by a $49.8 million impairment …

Manish Choudhary | 04 November 2026

Hamilton Insurance Group Q3 2026 10-Q: 66.2M Shares Outstanding

Hamilton Insurance Group, Ltd. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 4, 2026, covering financial results and operational disclosures for the third quarter.

Anjali Anand | 04 November 2026

Global Net Lease Files Investor Presentation Nov. 4, 2026

Global Net Lease, Inc. filed a Form 8-K on November 4, 2026, disclosing under Item 7.01 (Regulation FD) that the company prepared an investor presentation intended for use at conferences and meetings.

Shwetambri Chauhan | 04 November 2026
Support

Hi! How can we help you today?

Loading…